Karyopharm Therapeutics: 2Q Earnings Snapshot
NEWTON, Mass. (AP) _ Karyopharm Therapeutics Inc. (KPTI) on Tuesday reported a loss of $43.4 million in its second quarter.
The Newton, Massachusetts-based company said it had a loss of 71 cents per share.
The results beat Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of 97 cents per share.
The pharmaceutical company posted revenue of $9.5 million in the period.
Karyopharm Therapeutics shares have decreased 17% since the beginning of the year. The stock has fallen 56% in the last 12 months.